Temenos Blue Logo - PNG File.png
Temenos strengthens commitment to SaaS and the US with key executive appointments
July 25, 2024 08:30 ET | Temenos
GENEVA, Switzerland and NEW YORK, July 25, 2024 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN), the banking software company, today announced two key executive appointments to accelerate business growth...
21shares_B_Logotype_Marigold_Digital.png
21Shares Adds Staking to the 21Shares Cosmos ETP (ATOM) and the 21Shares Avalanche ETP (AVAX)
July 25, 2024 03:00 ET | 21Shares
ZURICH, 25 July 2024 – 21Shares AG (“21Shares”), one of the world’s largest issuers of crypto exchange traded products (ETPs), today announced that the firm has added staking to the 21Shares Cosmos...
[Ad-hoc-Mitteilung g
[Ad-hoc-Mitteilung gemäss Art. 53 KR] Verkäufe der Roche-Gruppe steigen im ersten Halbjahr 2024 um 5% (CER); starkes Wachstum im zweiten Quartal – Gewinnprognose für das Gesamtjahr erhöht
July 25, 2024 01:00 ET | F. Hoffmann-La Roche Ltd
Konzernverkäufe stiegen im ersten Halbjahr um 5%1 zu konstanten Wechselkursen (CER; stabil in CHF) dank starker Nachfrage sowohl nach Medikamenten als auch nach Diagnostika; ohne COVID-19-Produkte...
[Ad hoc announcement
[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 5% (CER) in first half of 2024; strong growth in second quarter – full-year earnings outlook raised
July 25, 2024 01:00 ET | F. Hoffmann-La Roche Ltd
Group sales were up by 5%1 at constant exchange rates (CER) (stable in CHF) in the first half, driven by the high demand for both our medicines and diagnostics; excluding COVID-19-related products,...
Sandoz Logo Sandoz Blue RGB_adjusted.png
Sandoz launches biosimilar Pyzchiva® (ustekinumab) across Europe, to treat chronic inflammatory diseases
July 25, 2024 01:00 ET | Sandoz Group
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Sandoz launches biosimilar Pyzchiva® (ustekinumab) across Europe, to treat chronic inflammatory diseases Launch across...
logo.png
Idorsia announces financial results for the first half 2024
July 25, 2024 01:00 ET | Idorsia Pharmaceuticals Ltd
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – July 25, 2024 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first half of 2024. Business highlights ...
2020-corporate-logo-email-small.png
Nestlé reports half-year results for 2024
July 25, 2024 01:00 ET | Nestlé S.A.
[Ad hoc announcement pursuant to Art. 53 LR] This press release is also available in Français (pdf) and Deutsch (pdf) Follow today's event live 14:00 CEST Investor Q&A audio webcast Full details...
logo.jpg
ArcelorMittal S.A.: ArcelorMittal announces publication of its second quarter 2024 sell-side analyst consensus figures
July 23, 2024 11:04 ET | ArcelorMittal S.A.
23 July 2024, 16:00 CET ArcelorMittal (‘the Company’) today announces the publication of its second quarter 2024 sell-side analyst consensus figures. The consensus figures are based on analysts’...
21shares_B_Logotype_Marigold_Digital.png
21Shares Expands its US Product Lineup with the Launch of the 21Shares Core Ethereum ETF (CETH)
July 23, 2024 09:30 ET | 21Shares
CETH builds on the Company’s mission to make crypto assets more accessible, straightforward for investors, and serves as a testament to the asset class’s global momentumNEW YORK, July 23, 2024 –...
Kuntarahoitus laskee
Kuntarahoitus laskee liikkeeseen 100 miljoonan euron lisäyksen viitelainaan osana joukkovelkakirjalainaohjelmaa
July 22, 2024 03:00 ET | Kuntarahoitus Oyj
Kuntarahoitus OyjPörssitiedote22.07.2024 klo 10.00 Kuntarahoitus laskee liikkeeseen 100 miljoonan euron lisäyksen viitelainaan osana joukkovelkakirjalainaohjelmaa Kuntarahoitus Oyj laskee 23.07.2024...